A Phase 1/2, Open‑Label, Multi‑Center, Dose Escalation, Dose Expansion, and Single Repeat Dose Study of TSRA‑196 in Adults With the PiZZ Genotype Who Have Lung and/or Liver Disease Associated With Severe Alpha‑1 Antitrypsin Deficiency

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 545e59b3675e19ed4d290f1c69ad5c5516cb624f
First added on: Nov 01, 2026